NYSEARCA:HRTS Tema Obesity & Cardiometabolic ETF (HRTS) Price, Holdings, & News $33.41 -0.56 (-1.65%) (As of 10/23/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatings About Tema Obesity & Cardiometabolic ETF (NYSEARCA:HRTS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HRTS alerts:Sign Up Key Stats Today's Range$33.33▼$33.8450-Day Range$32.99▼$35.3452-Week Range$26.26▼$36.03Volume13,114 shsAverage Volume24,554 shsMarket Capitalization$63.14 millionAssets Under Management$524,000.00Dividend YieldN/ANet Expense Ratio0.00%Aggregate RatingModerate Buy ETF OverviewThe Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.Read More… Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Tema Obesity & Cardiometabolic ETF ExpensesTypeHRTSNYSEARCA ETFsAll ETFsManagement Fee0.00%0.51%0.52%Other Expenses0.00%0.58%0.53%Total Expense0.00%0.73%0.71%Fee Waiver0.00%-0.68%-0.57%Net Expense0.00%0.58%0.59% Receive HRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address HRTS ETF News HeadlinesEli Lilly’s quest for obesity drugs leads to $1B bet on dark genomeSeptember 6, 2024 | seekingalpha.comHRTS: Generating Alpha In Obesity TreatmentJuly 25, 2024 | seekingalpha.comWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonOctober 24, 2024 | Porter & Company (Ad)HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of UpsideJuly 19, 2024 | seekingalpha.comWeight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up SupplyMay 29, 2024 | msn.comBlack menopausal women almost 5 times less likely to be on HRT than white womenApril 27, 2024 | yahoo.comSee More Headlines HRTS ETF - Frequently Asked Questions How have HRTS shares performed this year? Tema Obesity & Cardiometabolic ETF's stock was trading at $30.61 on January 1st, 2024. Since then, HRTS shares have increased by 9.1% and is now trading at $33.41. View the best growth stocks for 2024 here. How do I buy shares of Tema Obesity & Cardiometabolic ETF? Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Tema Obesity & Cardiometabolic ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Obesity & Cardiometabolic ETF investors own include Intuitive Surgical (ISRG), Adobe (ADBE), Accenture (ACN), Alpha Metallurgical Resources (AMR), Arista Networks (ANET), AppLovin (APP) and Arch Resources (ARCH). Fund Details Issuer Fund NameTema Cardiovascular and Metabolics ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:HRTS Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings40 Fund Statistics Assets Under Management$524,000.00 Average Daily Volume$0.00 Discount/Premium0.43% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares1,890,000Beta0.93 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Top 10 HRTS HoldingsAmgen (NASDAQ:AMGN)Holding Weight: 8.06%Eli Lilly and Company (NYSE:LLY)Holding Weight: 5.53%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 5.36%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 4.30%Novo Nordisk A/SHolding Weight: 4.03%Chugai Pharmaceutical Co., Ltd.Holding Weight: 3.69%AstraZeneca PLCHolding Weight: 3.62%Cytokinetics (NASDAQ:CYTK)Holding Weight: 3.45%BridgeBio Pharma (NASDAQ:BBIO)Holding Weight: 3.43%Crinetics Pharmaceuticals (NASDAQ:CRNX)Holding Weight: 3.17%Full Holdings DetailsHRTS Sector ExposureHRTS Industry Exposure This page (NYSEARCA:HRTS) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredAmerica’s Election NightmareThanks to a new law signed by President Biden, a small group of powerful people could decide who is installed ...Banyan Hill Publishing | SponsoredIt’s delivered 859% in 2.5 months…We’ve gotten a lot of messages asking… what should we buy if Trump wins? What should we buy if Kamala wins?...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.